Does SEMAGLUTIDE Cause Product communication issue? 842 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 842 reports of Product communication issue have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 1.4% of all adverse event reports for SEMAGLUTIDE.
842
Reports of Product communication issue with SEMAGLUTIDE
1.4%
of all SEMAGLUTIDE reports
1
Deaths
40
Hospitalizations
How Dangerous Is Product communication issue From SEMAGLUTIDE?
Of the 842 reports, 1 (0.1%) resulted in death, 40 (4.8%) required hospitalization, and 4 (0.5%) were considered life-threatening.
Is Product communication issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 842 reports have been filed with the FAERS database.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Product use in unapproved indication (2,613)
Wrong technique in product usage process (2,538)
What Other Drugs Cause Product communication issue?
EVOLOCUMAB (2,341)
ERENUMAB-AOOE (598)
SOMATROPIN (350)
PEGFILGRASTIM (333)
ETANERCEPT (122)
ALBUTEROL (121)
NIRMATRELVIR\RITONAVIR (70)
DENOSUMAB (68)
LEVODOPA (61)
TREPROSTINIL (58)
Which SEMAGLUTIDE Alternatives Have Lower Product communication issue Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B